FMC, Li-Cycle Holdings, Okta And Other Big Stocks Moving Lower On Monday
U.S. stocks traded slightly higher, with the Nasdaq Composite gaining around 10 points on Monday. Here are some big stocks recording losses in today’s session.
Li-Cycle Holdings Corp. (NYSE:LICY) shares dipped 41% to $1.34 after the company announced plans to halt construction work on its Rochester Hub project, pending completion of a comprehensive review of the go-forward strategy for the project.
Revolution Medicines, Inc. (NASDAQ:RVMD) fell 38% to $17.31 after the company announced it presented clinical activity and safety data from its Phase 1/1b trial of RMC-6236.
Ambrx Biopharma Inc. (NASDAQ:AMAM) declined 22% to $6.58. Ambrx announced ARX517, a PSMA-targeted ADC, demonstrates 52% PSA50 (≥50% Reduction) and a highly differentiated safety and PK profile in patients with mCRPC, who progressed on multiple FDA-approved treatments.
FMC Corporation (NYSE:FMC) fell 13.7% to $57.76 after the company updated its third-quarter and FY23 outlook.
VinFast Auto Ltd. (NASDAQ:VFS) fell 11.4% to $4.76. The company recently entered into a standby equity agreement with YA LL PN for an aggregate subscription amount of up to $1 billion.
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) declined 11.4% to $6.25. NewAmsterdam Pharma named Ian Somaiya as Chief Financial Officer.
FingerMotion, Inc. (NASDAQ:FNGR) fell 8.8% to $5.76.
YPF Sociedad Anónima (NYSE:YPF) fell 8.5% to $11.24.
Okta, Inc. (NASDAQ:OKTA) declined 7.6% to $69.85 on continued downward momentum after a threat actor breached its support system and viewed certain customer files. Also, Keybanc maintained an Overweight rating on the stock but lowered its price target from $106 to $95.
World Acceptance Corporation (NASDAQ:WRLD) fell 6.8% to $103.71 after BMO Capital maintained an Underperform rating on the stock and lowered its price target from $58 to $56.
Perfect Corp. (NYSE:PERF) fell 6.8% to $2.61.
Formula Systems (1985) Ltd. (NASDAQ:FORTY) declined 6% to $55.97.
Now Read This: Hexcel Likely To Report Higher Q3 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts
